Format

Send to

Choose Destination

See 1 citation found by title matching your search:

PLoS One. 2014 Jun 26;9(6):e100860. doi: 10.1371/journal.pone.0100860. eCollection 2014.

Factors determining immunological response to vaccination against tick-borne encephalitis virus in older individuals.

Author information

1
Division of Medical Microbiology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
2
Division of Infectious Diseases, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
3
Division of Medical Services, Department of Microbiology, County Hospital Ryhov, Jönköping, Sweden.
4
Department of Infectious Diseases, County Hospital Kalmar, Kalmar, Sweden.
5
Clinic of Infectious Diseases, Linköping University Hospital, Linköping, Sweden.
6
Public Health Agency of Sweden, Stockholm, Sweden.
7
Åland Central Hospital, Mariehamn, Åland, Finland.
8
Division of Infectious Diseases, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden; Clinic of Infectious Diseases, Linköping University Hospital, Linköping, Sweden.
9
Division of Medical Microbiology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden; Division of Medical Services, Department of Microbiology, County Hospital Ryhov, Jönköping, Sweden.

Abstract

We performed a cross-sectional study including 533 individuals (median age 61) from the highly TBE endemic Åland Islands in the archipelago between Sweden and Finland. Blood samples, questionnaires and vaccination records were obtained from all study participants. The aim was to investigate if there was any association between TBEV antibody titer and 12 health-related factors. Measurement of TBEV IgG antibodies was performed using two commercial ELISA assays (Enzygnost and Immunozym), and a third in-house rapid fluorescent focus inhibition test was used to measure TBEV neutralizing antibodies. The age of the individual and the number of vaccine doses were the two most important factors determining the immunological response to vaccination. The response to each vaccine dose declined linearly with increased age. A 35 year age difference corresponds to a vaccine dose increment from 3 to 4 to achieve the same immunological response. Participants previously vaccinated against other flaviviruses had lower odds of being seropositive for neutralizing TBEV antibodies on average, while participants with self-reported asthma had higher odds of being seropositive. By comparing the 3 serological assays we show that the Enzygnost and Immunozym assay differ due to choice of cutoffs, but not in overall accuracy.

PMID:
24967619
PMCID:
PMC4072701
DOI:
10.1371/journal.pone.0100860
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center